go back

Idecabtagene Vicleucel (Abecma) CAR-T Therapy

Delaware rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

How much rates vary

Professionalmedian $1,905,461 · 10th to 90th $1,905,461 to $1,905,461
professional $1,905,461

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$1,905,460.72
Median
$1,905,460.72
Typical High
$1,905,460.72